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The addition of sialic acid to O-linked glycans of 
the T-cell co-receptor CD8 is regulated during
thymocyte differentiation. Two recent papers have
shown that this glycosylation changes the avidity of
the interaction between CD8 and MHC class I
proteins, potentially altering signalling thresholds in
thymocyte differentiation.
During T-cell development in the thymus, expression
of the co-receptors CD4 and CD8 precedes that of 
the T-cell antigen receptor (TCR). CD4 and CD8 are
expressed together at the immature stage (double
positive, DP cells) after rearrangement and expression
of the TCRβ chain gene on the cell surface as part of
the pre-TCR, but before rearrangement and expres-
sion of the TCRα chain gene. During the DP stage,
thymocytes rearrange TCRα genes until the TCRαβ
protein combination is capable of recognising a ligand
— a short peptide bound to a major histocompatibility
(MHC) molecule — that is sufficient to transduce a
signal for positive (or negative) selection. With sig-
nalling for positive selection, the cells differentiate to
CD4+CD8– or CD4–CD8+ single positive (SP) thymo-
cytes, whereas negative selection results in deletion of
thymocytes.
CD8 and CD4 are not simply markers of differentia-
tion, but function as co-receptors for the TCR. Each
interacts with MHC at a site distinct from that recog-
nised by the TCR, with CD8 binding to MHC class I
molecules and CD4 binding to MHC class II molecules.
It is generally considered that these co-receptors
interact with the same peptide–MHC molecule as is
recognised by the TCR. However, they can also act as
adhesion molecules, binding to MHC irrespective of
the peptide bound to the MHC molecule [1]. Such
‘non-cognate’ binding has often been dismissed as an
artefact of overexpression, but new data from the labs
of Ellis Reinherz [2] and Steve Jameson [3] now show
that the strength of non-cognate binding between
CD8 and MHC class I molecules is developmentally
regulated, being much stronger in immature DP thy-
mocytes than in mature CD4–CD8+ SP thymocytes or
mature peripheral CD8+ T cells (Figure 1).
The glycosylation of CD8 is regulated during T-cell
differentiation [2,4] and T-cell activation [5]. This is
particularly evident with CD8β, where O-linked glycans
become sialylated on activation [5] or on maturation
from DP to SP subsets [2]. The lectin peanut agglutinin
(PNA) binding is a venerable surrogate marker for thy-
mocyte maturation [6]. PNA binds ‘core 1’ O-glycans
with a terminal galactose moiety and binding is lost
with addition of a sialic acid residue to the core 1
branch, or by addition of sugar residues to form
‘core 2’ branches on the glycan (Figure 2). PNA stain-
ing of thymocytes is primarily on DP cells, with PNA
reactivity being lost upon maturation to SP cells. The
main PNA-binding proteins on thymocytes are CD8,
CD43 and CD45 [4]. Notably, the sialyltransferase
ST3Gal-1, which adds sialic acid to the core 1
O-glycan Galβ1-3GalNAc-Ser/Thr is induced in
medullary thymocytes, which represent the SP popu-
lation ([7,8] and references in [9]). 
MHC class I tetramers, made by crosslinking
biotinylated peptide–MHC class I monomers with avidin
have been used extensively to stain antigen-specific
CD8+ T cells. It is accepted that these tetramers bind
only to T cells with a TCR that recognises the specific
peptide–MHC ligand (‘cognate binding’) and, unlike
MHC class II tetramers, where binding seems to be
independent of CD4, CD8 aids in tetramer binding
[10]. Therefore, it was a surprising result when Bosselut
and colleagues [11] showed TCR-independent binding
of MHC class I tetramers to CD8αβ on thymocytes.
Comparison of tetramer binding on thymocyte subsets
shows clearly that there is no binding to CD4+ SP or
CD4–CD8– (double-negative, DN) cells. The DP cells
show strong tetramer staining which is reduced in the
subsets of this population where CD8 expression is
decreased. Tetramer binding is strongly reduced in the
CD8 SP cells [3]. Tetramer binding on the DP cells is
independent of the MHC haplotype and of TCR: TCRα–/–
thymocytes are stained, even though they cannot
express an αβ TCR [2,3]. Binding requires CD8β expres-
sion as part of the CD8αβ heterodimer, because there is
no staining of either CD8α–/– (no CD8 expressed on
the cell surface) or CD8β–/– (CD8αα expressed on the
cell surface) thymocytes [2]. Binding is blocked by
both anti-CD8α or anti-CD8β antibodies [2,3].
Neuraminidase treatment of SP thymocytes to
remove sialic acid greatly increases their binding to
MHC class I tetramer, as well as slightly increasing the
binding to DP cells [2,3]. In concert with this, PNA-
binding sites are also revealed on the SP cells [2–4].
Mice deficient for ST3Gal-1 enzyme have little overt
defect in thymocyte development, but have a loss of
naïve mature CD8+ peripheral T cells [9]. There is a
deficiency in the number of mature, positively selected,
CD8+ SP thymocytes and the CD8+ SP cells show
increased binding of MHC class I tetramer, although
not to the same extent as with neuraminidase treat-
ment [2]. Thus it is clear that sialylation is responsible
for the loss of the non-cognate CD8–MHC class I
interaction that occurs after positive selection. More
evidence that the change in the avidity of the
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CD8–MHC class I interaction is regulated by positive
selection comes from experiments comparing tetramer-
staining of TCRα–/– thymocytes, OT1 TCR transgenic
(OT1) thymocytes and thymocytes from OT1 mice
deficient in the peptide loading protein TAP. Positive
selection of DP thymocytes in OT1 mice is highly effi-
cient, but is blocked in the OT1 TAP–/– thymus
because of the lack of peptide loading onto MHC
class I molecules, and as mentioned, the TCRα–/– thy-
mocytes are unable to undergo positive selection
because they have no TCR. Tetramer staining of both
TCRα–/– and OT1 TAP–/– DP thymocytes is strong, but
is reduced in the OT1 DP cells, indicating that active
positive selection results in decreased tetramer reac-
tivity [3]. The sialylation may also have an effect on
repertoire selection because a small but statistically
significant difference is seen in the TCRβ chain reper-
toire when comparing ST3Gal–/– to control animals [2].
Thus the interaction between CD8αβ and MHC
class I molecules is turned off during the develop-
mental programme by sialylation of core 1 O-linked
glycans of CD8. The extracellular parts of CD8α and
CD8β consist of an immunoglobulin-like recognition
domain and a ‘stalk’ region where the O-linked
glycans are located. It is thought that these glycans
hold the structure in an extended conformation in
order that the stalk can reach from the T-cell mem-
brane to the membrane-proximal part of the MHC
class I molecule on the antigen-presenting cell [5,12].
The role of CD8 sialylation in changing the avidity for
MHC class I molecules is unknown. Moody and co-
workers [2] have suggested that the sialylation forces
CD8α and CD8β apart, thus reducing the ability to
bind MHC class I, since the CD8αα–MHC class I inter-
action involves residues from both members of the αα
dimer [13,14]. 
Another possibility relates to the formation of
ordered arrays of molecules on the cell surface by
glycan-binding, crosslinking proteins such as galectins,
which could alter the availability of CD8 for binding the
MHC class I tetramers. For example, galectin-3 binds
to particular N-linked glycan structures and reduces
T-cell activation by restricting TCR clustering [15].
Similarly, galectin-1, which recognises CD4 and other
glycoproteins through core 2 O-glycans, has immuno-
modulatory effects similar to antagonist ligands [16].
Perhaps a similar interaction involving CD8 O-linked
glycans could be altered by sialylation and therefore
affect the CD8–MHC class I interaction.
The non-cognate CD8–MHC class I interaction pre-
sumably has a role in thymocyte development. As
demonstrated by Daniels and co-workers [3], the
interaction is sufficient for T-cell binding to an MHC
class I surface. Earlier work showed that TCR activa-
tion of CD8+ cells increases CD8–MHC class I non-
cognate binding, and that the CD8–MHC class I
interaction increases activity of the CD8-associated
kinase Lck [17,18]. Activation of peripheral T cells
results in reduction of sialylation [5,9], although no
change in the non-cognate CD8–MHC class I interac-
tion has been described. Immature thymocytes are
more sensitive to stimuli than are mature cells [19,20],
suggesting that the role of the non-cognate CD8–MHC
class I interaction could be to pre-sensitise the cells
so they can respond to a weak stimulus. Furthermore,
the non-cognate interaction could pre-concentrate
MHC class I molecules in the immunological synapse
for testing by the TCR, thus compensating for the low
level of TCR on pre-positive selection DP cells [2]. It
remains to be seen whether analogous changes in
non-cognate CD4–MHC class II interactions occur
during thymocyte development, but this should be an
area of strong interest in the near future.
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Figure 1. Non-cognate MHC class I
binding to CD8αβ is regulated during pos-
itive selection. 
The DP thymocyte (left) binds MHC class
I tetramers irrespective of the peptide
bound to the MHC class I molecule. The
SP thymocyte (right) can only bind MHC
class I tetramers if the peptide in the MHC
groove is specifically recognised by the
TCR of that cell. (Tetramer is shown
binding through two MHC class I units for
clarity.) This change in the binding prop-
erties of MHC class I molecules to CD8 is
mediated by sialylation of CD8αβ, in par-
ticular of the CD8β chain. The relevant
sialyltransferase, ST3Gal-1, is induced
during DP to SP differentiation. Similarly,
DP cells bind PNA due to lack of sialyla-
tion of membrane glycoproteins including
CD8. PNA-binding is lost in the SP cells
because of sialylation.
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Figure 2. O-linked glycan synthesis
involved in CD8αβ interaction with PNA
and the non-cognate interaction with
MHC class I molecules. 
The unsialylated core 1 O-glycan is pro-
duced by core 1 galactosyltransferase,
resulting in the structure recognised by
PNA and required for non-cognate CD8αβ
interaction with MHC class I molecules.
The sialyltransferase ST3Gal-1 can then
produce the sialylated core 1 O-glycan,
which does not bind PNA and abrogates
the non-cognate interaction between
CD8αβ and MHC class I. The core 2 N-
acetylglucosaminyltransferase
(C2GlcNAc-T) has access to the structure
after ST3Gal-1.
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